Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Insect Sci ; 28(4): 1139-1146, 2021 Aug.
Article in English | MEDLINE | ID: mdl-32510773

ABSTRACT

Use of genetically engineered plants that express insecticidal Cry proteins derived from Bacillus thuringiensis (Bt) have been proven efficacious for managing lepidopteran pests. However, in some cases herbivores that are not targeted by the Bt trait have increased in importance. It has been suggested that reduced caterpillar damage to Bt crops could lead to decreased levels of induced plant defensive compounds which might benefit other non-target herbivores. Here we investigated the potential effect of reduced damage by larvae of Mythimna separata on aphid populations in Bt corn. We compared the performance of Rhopalosiphum maidis feeding on non-Bt corn plants that had been infested by M. separata larvae or were uninfested. The results showed that caterpillar-infested corn plants significantly reduced the fitness of R. maidis leading to a prolonged nymphal development time, reduced adult longevity and fecundity compared to uninfested plants. Consequently, the population growth rate of corn aphids feeding on caterpillar-infested corn plants was significantly lower than on uninfested plants. As expected, the aphids performed significantly better on Lepidoptera-resistant Bt corn than on non-Bt corn when plants were infested with M. separata, since the caterpillars caused very little damage to the Bt plants. The current findings indicate that reduced M. separata infestation could benefit aphid development in Bt corn. Bt corn has the potential to be commercialized in China in the near future and aphids and other non-target pests should be monitored in the farming fields.


Subject(s)
Aphids/growth & development , Moths/growth & development , Plants, Genetically Modified , Zea mays/genetics , Animals , Bacillus thuringiensis Toxins/genetics , Bacterial Proteins/genetics , Crops, Agricultural/genetics , Endotoxins/genetics , Hemolysin Proteins/genetics , Herbivory , Pest Control, Biological
2.
J Matern Fetal Neonatal Med ; 31(11): 1454-1461, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28412885

ABSTRACT

OBJECTIVE: To investigate whether antenatal taurine supplementation improves neural stem cell proliferation in rats with fetal growth restriction (FGR) through regulating the activity of Rho family factors. METHODS: FGR models were established via food restriction throughout pregnancy. Pregnant rats were randomly divided into the control group, the FGR group (given 40% of the normal daily feeding in the control group), and the Taurine group (FGR model treated with 300 mg/kg·d taurine from gestational day seven). Expression of fatty acid binding protein-7 (FABP-7), Rho-associated coiled coil-forming protein kinase (ROCK2), Ras homolog gene family member A (RhoA), and rac in the brains of newborn rats was detected by reverse transcription-polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and Western blotting (WB). RESULTS: Relative FABP7 mRNA levels, the optical density (OD) values of FABP7-positive cells and the expression levels of the tested proteins all demonstrated that the number of neural stem cells (NSCs) in brain tissue was lower in the FGR group than in the control group but was significantly increased after antenatal taurine supplementation (p < .05). Compared with the control group, the mRNA and protein levels of RhoA and ROCK2 were higher in the FGR group but lower in the Taurine group (p < .05). In contrast, the rac mRNA level was lower in the FGR group than in the control group but was higher in the Taurine group (p < .05). CONCLUSIONS: Taurine prenatal supplementation improved neural stem cell proliferation in rats with FGR by inhibiting the activity of Rho family factors.


Subject(s)
Fetal Growth Retardation/drug therapy , Neural Stem Cells/drug effects , Taurine/therapeutic use , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases/metabolism , Animals , Animals, Newborn , Apoptosis/drug effects , Brain/metabolism , Cell Proliferation/drug effects , Dietary Supplements , Drug Evaluation, Preclinical , Fatty Acid-Binding Protein 7/metabolism , Female , Food Deprivation , Male , Pregnancy , Random Allocation , Rats, Sprague-Dawley , Taurine/pharmacology
3.
Nutr Neurosci ; 20(7): 409-415, 2017 Sep.
Article in English | MEDLINE | ID: mdl-26906683

ABSTRACT

OBJECTIVES: Taurine is one of the most abundant amino acids in the central nervous system and has important functions in the promotion of brain development. This study aimed to determine the mechanistic role of taurine in improving neuronal proliferation, stem cell proliferation, and neural differentiation. METHODS: The data for this review were primarily retrieved from the PubMed database from 1985 to 2015 in English. The search string included the keywords taurine, brain development, neuronal, stem cell, proliferation, differentiation, and others. Relevant publications were identified, retrieved, and reviewed. RESULTS: This review introduces the source, function, and mechanisms of taurine in brain development and provides additional detail regarding the mechanistic role of taurine in improving neuronal proliferation, stem cell proliferation, and neural differentiation. Many studies concerning these aspects are discussed. CONCLUSIONS: Taurine plays an important role in brain development, including neuronal proliferation, stem cell proliferation, and differentiation, via several mechanisms. Taurine can be directly used in clinical applications to improve brain development because it has no toxic effects on humans.


Subject(s)
Cell Differentiation/drug effects , Cell Proliferation/drug effects , Neural Stem Cells/drug effects , Taurine/pharmacology , Animals , Cells, Cultured , Humans , Models, Animal , Neural Stem Cells/cytology , Neurons/cytology , Neurons/drug effects , Neuroprotection/drug effects
4.
Zhongguo Dang Dai Er Ke Za Zhi ; 18(11): 1158-1165, 2016 Nov.
Article in Chinese | MEDLINE | ID: mdl-27817785

ABSTRACT

OBJECTIVE: To study the possible effect of antepartum taurine supplementation in regulating the activity of Rho family factors and promoting the proliferation of neural stem cells in neonatal rats with fetal growth restriction (FGR), and to provide a basis for antepartum taurine supplementation to promote brain development in children with FGR. METHODS: A total of 24 pregnant Sprague-Dawley rats were randomly divided into three groups: control, FGR, and taurine (n=8 each ). A rat model of FGR was established by food restriction throughout pregnancy. RT-PCR, immunohistochemistry, and Western blot were used to measure the expression of the specific intracellular markers for neural stem cells fatty acid binding protein 7 (FABP7), Rho-associated coiled-coil containing protein kinase 2 (ROCK2), ras homolog gene family, member A (RhoA), and Ras-related C3 botulinum toxin substrate (Rac). RESULTS: The FGR group had significantly lower OD value of FABP7-positive cells and mRNA and protein expression of FABP7 than the control group, and the taurine group had significantly higher OD value of FABP7-positive cells and mRNA and protein expression of FABP7 than the FGR group (P<0.05). The FGR group had significantly higher mRNA expression of RhoA and ROCK2 than the control group. The taurine group had significantly higher mRNA expression of RhoA and ROCK2 than the control group and significantly lower expression than the FGR group (P<0.05). The FGR group had significantly lower mRNA expression of Rac than the control group. The taurine group had significantly higher mRNA expression of Rac than the FGR and control groups (P<0.05). The FGR group had significantly higher protein expression of RhoA and ROCK2 than the control group. The taurine group had significantly lower protein expression of RhoA and ROCK2 than the FGR group (P<0.05). CONCLUSIONS: Antepartum taurine supplementation can promote the proliferation of neural stem cells in rats with FGR, and its mechanism may be related to the regulation of the activity of Rho family factors.


Subject(s)
Cell Proliferation/drug effects , Fetal Growth Retardation/drug therapy , Neural Stem Cells/drug effects , Taurine/pharmacology , rho-Associated Kinases/genetics , rhoA GTP-Binding Protein/genetics , Animals , Animals, Newborn , Body Weight/drug effects , Brain/drug effects , Fatty Acid-Binding Protein 7/analysis , Female , Male , Neural Stem Cells/physiology , Rats , Rats, Sprague-Dawley , rho-Associated Kinases/analysis , rhoA GTP-Binding Protein/analysis
5.
Medicine (Baltimore) ; 95(17): e3564, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27124067

ABSTRACT

To compare differences in metabolites between newborns with intrauterine growth restriction (IUGR) and those who are appropriate for gestational age (AGA) in order to understand the changes in metabolites of newborns with IUGR and to explore the possible metabolic mechanism of tissue and organ damages in patients with IUGR, with the ultimate goal of providing the basis for clinical intervention.A total of 60 newborns with IUGR and 60 AGA newborns who were hospitalized in the neonatal intensive care unit of our hospital between January 2011 and December 2015 and who underwent metabolic disease screening were enrolled in this study. The differences in 21 amino acids and 55 carnitines in peripheral blood, as well as changes in the ratios of free carnitine and acylcarnitine to total carnitine, were compared.Metabolites, particularly alanine, homocysteine, leucine, methionine, ornithine, serine, tyrosine, isovaleryl carnitine, and eicosenoyl carnitine, differed according to newborns' birth weight (<3rd percentile, 3rd-5th percentiles, 5th-10th percentiles, and 10th-90th percentiles), with those with lower birth weight showing the greater difference (P < 0.05). Metabolites also differed by gestational age, and the differences observed were mainly as follows: preterm and full-term newborns showed differences in metabolites, mainly in alanine, proline, cerotoyl carnitine, and tetradecanedioyl carnitine (P < 0.05); preterm and full-term AGA newborns showed differences in metabolites, mainly in alanine, glutamine, homocysteine, pipecolic acid, proline, heptanoyl carnitine, and sebacoyl carnitine (P < 0.05); and preterm and full-term newborns with IUGR showed differences in metabolites, mainly in arginine, glutamic acid, homocysteine, histidine, leucine, isoleucine, ornithine, serine, threonine, tryptophan, valine, heptanoyl carnitine, decanoyl carnitine, linoleyl carnitine, methylmalonyl carnitine, glutarylcarnitine, sebacoyl carnitine, hydroxyacetyl carnitine, and hydroxyhexadecancenyl carnitine (P < 0.05). Among newborns with IUGR, metabolites differed among males and females, mainly in aspartic acid, glutamic acid, and hexacosenoic acid (P < 0.05). Birth weight had no significant effects on free carnitine concentration or on the ratios of free carnitine and acylcarnitine to total carnitine (P < 0.05).IUGR infants exhibit significant abnormalities in amino acid and acylcarnitine metabolism, especially those with birth weight below the third percentile. With increasing birth weight, amino acids and acylcarnitines showed compensatory increases or reductions, and when birth weight reached the 10th percentile, the newborns with IUGR resembled the AGA newborns.


Subject(s)
Fetal Growth Retardation/physiopathology , Metabolic Diseases/diagnosis , Metabolic Diseases/physiopathology , Metabolomics/methods , Amino Acids/blood , Carnitine/analogs & derivatives , Carnitine/blood , Female , Gestational Age , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Male , Neonatal Screening , Reference Values , Research
6.
Chest ; 149(5): 1269-75, 2016 05.
Article in English | MEDLINE | ID: mdl-26836942

ABSTRACT

BACKGROUND: This study explored the sensitivity and specificity of ultrasound for diagnosing transient tachypnea of the newborn (TTN). METHODS: Ultrasound was performed by one export. Patients were placed in a supine, lateral recumbent, or prone position. The probe was placed perpendicular or parallel to the ribs, and each region of the lung was scanned. The scan results were compared with conventional chest radiographic results. RESULTS: A total of 1,358 infants were included in this study. We identified 412 cases without pulmonary diseases, 228 TTN cases, 358 respiratory distress syndrome (RDS) cases, 85 meconium aspiration syndrome (MAS) cases, 215 infectious pneumonia cases, and 60 other cases. The primary ultrasonic characteristic of TTN was pulmonary edema. "White lung" or a "compact B-line" were only observed in severe cases, whereas TTN primarily presented as pulmonary interstitial syndrome or "double lung point." Furthermore, double lung point could appear during the recovery period of severe TTN or RDS, MAS, and pneumonia. Lung consolidation with air bronchograms was not observed in TTN patients. The results showed that white lung or a compact B-line exhibited a sensitivity of 33.8% and a specificity of 91.3% in diagnosing TTN, whereas double lung point exhibited a sensitivity of 45.6% and a specificity of 94.8% in diagnosing severe TTN. CONCLUSIONS: Pulmonary edema, alveolar-interstitial syndrome, double lung point, white lung, and compact B-line are the primary ultrasound characteristics of TTN. Ultrasonic diagnosis of TTN based on these findings is accurate and reliable. TTN can be ruled out in the presence of lung consolidation with air bronchograms.


Subject(s)
Lung/diagnostic imaging , Pulmonary Edema/diagnostic imaging , Transient Tachypnea of the Newborn/diagnostic imaging , Case-Control Studies , Female , Humans , Infant, Newborn , Male , Meconium Aspiration Syndrome/diagnostic imaging , Pneumonia/diagnostic imaging , Respiratory Distress Syndrome, Newborn/diagnostic imaging , Retrospective Studies , Sensitivity and Specificity , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...